Jinxin Fertility Group Limited (abbreviated as JXR) disclosed a Next Day Disclosure Return after repurchasing 36,500 ordinary shares on 26 August 2026 via on-market transactions at prices between HK$2.275 and HK$2.300, for a total consideration of HK$0.08 million (VWAP: HK$2.2909).

Key takeaways

1. Latest repurchase • Shares bought back: 36,500, representing 0.0013% of JXR’s outstanding share count before the transaction. • Average repurchase price: HK$2.29 per share. • Treasury shares created: the entire batch is being held as treasury stock, raising the treasury share balance to 36,500.

2. Share capital position (post-transaction) • Issued shares (excluding treasury shares): 2,705.01 million. • Treasury shares on hand: 36,500. • Total issued shares (including treasury): unchanged at 2,705.04 million.

3. Ongoing repurchase activity • Shareholder mandate date: 25 June 2026, authorising buy-backs of up to 262.51 million shares. • Shares repurchased under this mandate to date: 12.58 million, equivalent to 0.48% of the issued share base at mandate date. • Moratorium: No new share issues or treasury share disposals may occur before 25 September 2026 without prior HKEX approval.

4. Pending cancellations • Separately, 92.47 million shares (3.42% of current issued shares) were repurchased between 27 March and 25 August 2026 and remain outstanding awaiting cancellation. Average prices per share across those trades ranged between HK$1.97 and HK$2.47.

Context

JXR continues to utilise its authorised repurchase mandate, albeit at a measured pace—the latest trade adds marginally to treasury holdings while the bulk of earlier repurchases are queued for cancellation. The company affirms that all transactions comply with Hong Kong Stock Exchange regulations and the terms of its June 2026 explanatory statement.